FGF23 and hypophosphatemia: Clinical use of phosphate dietary supplements to correct hypophosphatemia is largely limited to use in inherited disorders of phosphorus metabolism causing phosphate wasting and tumor-induced osteomalacia resulting in hypophosphatemia because of excessive tumor-secreted FGF-23 decreasing tubular phosphate reabsorption [1].